Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4149/NEO_2016_619PMID 27596300
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology and risk factors of urothelial bladder cancer.

  2013cited by this paper
• EMT and MET as paradigms for cell fate switching.

  2012cited by this paper
• Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.

  2012cited by this paper
• Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.

  2012cited by this paper
• Biological activities of thymosin ß4 defined by active sites in short peptide sequences

  2010cited by this paper
• Prognostic impact of CD133 expression in gastric carcinoma.

  2010cited by this paper
• Overexpression of thymosin beta4 increases pseudopodia formation in LNCaP prostate cancer cells.

  2009cited by this paper
• Bladder cancer

  2009cited by this paper
• Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front

  2008cited by this paper
• Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells

  2008cited by this paper
• Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

  2007cited by this paper
• Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression

  2007cited by this paper
• Thymosin Beta 4 Induces Hair Growth via Stem Cell Migration and Differentiation

  2007cited by this paper
• Thymosin β4 triggers an epithelial–mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase

  2007cited by this paper
• Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

  2006cited by this paper
• Mammalian cadherins and protocadherins: about cell death, synapses and processing.

  2005cited by this paper
• Cadherins and catenins in breast cancer.

  2005cited by this paper
• Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development.

  2004cited by this paper
• Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma.

  2004cited by this paper
• Epithelial-mesenchymal transitions in development and pathologies.

  2003cited by this paper
• MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer

  2003cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Bladder cancer.

  1998cited by this paper

• Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers

  2020cites this paper
• Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

  2017cites this paper